World's Best Scientists 2026 revealed!
Oncology
H-index 20

Oncology

0030-2414

Published by: Karger Publishers

https://www.karger.com/Journal/Home/223857

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1173 135 150 20

Additional Metrics

Number of Best Scientists*: 183
Documents by Best Scientists*: 180
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 85
SCIMAGO SJR: 0.489
Impact Factor: 1.8

Overview

Top Research Topics at Oncology?

Oncology was organized to reinforce research efforts on Internal medicine, Oncology, Cancer, Chemotherapy and Pathology. The journal addresses concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology, Endocrinology and Surgery. The research on Oncology tackled can also make contributions to studies in the areas of Colorectal cancer, Carcinoma, Radiation therapy and Disease.

The journal emphasizes research on Colorectal cancer, which includes concerns such as Gastrointestinal cancer. Chemotherapy study tackled is connected to the field of Regimen. It facilitates discussions on Pathology that incorporate concepts from other fields like Cancer research and Metastasis.

The journal explores issues in Clinical trial which can be linked to other research areas like Referral and Intensive care medicine. Metastatic breast cancer is part of Breast cancer studies tackled in Oncology.

  • Internal medicine (45.46%)
  • Oncology (33.78%)
  • Cancer (19.15%)

What are the most cited papers published in the journal?

  • VEGF as a key mediator of angiogenesis in cancer. (1008 citations)
  • Chronic inflammation and cancer. (628 citations)
  • Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer (600 citations)

Research areas of the most cited articles at Oncology:

The journal papers are organized to reinforce research efforts on Internal medicine, Oncology, Cancer, Pathology and Chemotherapy. The published articles address concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology and Surgery. The study of Cancer in the published papers encompasses disciplines such as Cancer research, as well as fields such as Immunology and Carcinogenesis, all of which overlap with one another.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

The journal aims to foster the development of research in Internal medicine, Oncology, Cancer, Gastroenterology and Chemotherapy. The journal aims to address concerns in Internal medicine, specifically in the areas of Retrospective cohort study, Clinical trial, Prostate cancer, Hepatocellular carcinoma and Breast cancer. Aside from discussions in Oncology, the journal also deals with the subject of MEDLINE which intersects with Randomized controlled trial disciplines.

The journal explores themes in Cancer like Immune checkpoint inhibitors and links them with other fields of study like In patient. Some problems in Gastroenterology that were presented in the journal overlapped with concepts under Cisplatin, Regimen, Gemcitabine, Primary tumor and Cohort. Oncology links adjacent topics like Chemotherapy with Treatment options.

The most cited articles from the last journal are:

  • Cholangiocarcinoma Evaluation via Imaging and Artificial Intelligence. (6 citations)
  • Minority Enrollment to Clinical Trials: Road to Increased Access. (5 citations)
  • Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Oncology (based on the number of publications) are:

  • Masatoshi Kudo (109 papers) absent at the last edition,
  • Yoshihiko Maehara (61 papers) absent at the last edition,
  • Maurie Markman (58 papers) absent at the last edition,
  • Bruce D. Cheson (47 papers) absent at the last edition,
  • Keizo Sugimachi (42 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Oncology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (279 papers) published 5 papers at the last edition, 2 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (229 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Harvard University (137 papers) published 5 papers at the last edition, 4 more than at the previous edition,
  • Johns Hopkins University (117 papers) absent at the last edition,
  • National Institutes of Health (104 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.89% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.52% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.48% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.87% of all publications and 66.13% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Nursing Oncology: Requirements and Career Path

In the course of our extensive research in the realm of Oncology, a focus on nurses who have chosen the path of Oncology often takes a back seat. However, the role of oncology nurses is increasingly vital in the patient care and pathways of treatment for cancer. Oncology nurses don’t only attend to administering chemotherapy and assisting in radiation procedures, but provide moral support to patients, explain the potential side effects of treatment procedures, regularly monitor the patient's physical condition, and serve as an essential communication channel between doctors and patients.

For nurses interested in forging a career in Oncology or those in Louisiana considering an oncology nursing specialization, familiarizing oneself with the louisiana nursing license requirements board of nursing requirements is crucial.

This involves meeting the education and licensure requirements, with specialized certification for Oncology being an essential step forward in one's career. Additionally, oncology nursing necessitates a solid foundation in the understanding of cancer's pathology, treatments, and supportive care. This equips the nurse to contribute significantly in multidisciplinary teams, cope with bereavement issues and palliative care and be a core part of clinical trials.

The role of oncology nurses in research is an expansive field in itself. Studies conducted by oncology nurses contribute significantly to our understanding of cancer patients' experiences and the efficacy of nursing interventions, which is paramount in improving cancer care through research.

Top Publications

  • Applications of Blockchain Technology for Data-Sharing in Oncology: Results from a Systematic Literature Review.

    Alevtina Dubovitskaya;Petr Novotny;Zhigang Xu;Fusheng Wang

    (2020)
    89 Citations
  • Feasibility and Usability Aspects of Continuous Remote Monitoring of Health Status in Palliative Cancer Patients Using Wearables

    Matea Pavic;Vanessa Christina Klaas;Gudrun Theile;Johannes Kraft

    (2020)
    55 Citations
  • Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.

    Yuwa Ando;Tomokazu Kawaoka;Kei Amioka;Kensuke Naruto

    (2021)
    50 Citations
  • Machine Learning and Imaging Informatics in Oncology.

    Huan-Hsin Tseng;Lise Wei;Sunan Cui;Yi Luo

    (2020)
    47 Citations
  • Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA.

    Saranya Akumalla;Russell Madison;Douglas I. Lin;Alexa B. Schrock

    (2020)
    39 Citations
  • The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials

    (2021)
    35 Citations
  • Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.

    Giuseppe Di Lorenzo;Luciana Buonerba;Concetta Ingenito;Felice Crocetto

    (2020)
    34 Citations
  • Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience.

    Giuseppina Novo;Daniela Di Lisi;Enrico Bronte;Francesca Macaione

    (2020)
    29 Citations
  • Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma

    Atsushi Hiraoka;Takashi Kumada;Toshifumi Tada;Shinya Fukunishi

    (2020)
    28 Citations
  • Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.

    Yuwa Ando;Tomokazu Kawaoka;Yosuke Suehiro;Kenji Yamaoka

    (2020)
    27 Citations

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA often opens doors to various complementary online degrees and certifications that can enhance your expertise and job prospects. For instance, nurses aiming to advance their clinical skills may consider post masters FNP programs. These programs offer a streamlined path to becoming a Family Nurse Practitioner, allowing for greater autonomy and patient care responsibilities.

Nutrition and wellness play a pivotal role in healthcare, making an online nutrition degree a valuable addition for medical professionals interested in dietetics and holistic patient care. Such programs provide flexibility and cost-effectiveness while preparing graduates for a wide range of roles in health promotion.

For registered nurses seeking to climb the professional ladder, enrolling in one of the cheapest RN to BSN online programs can be an excellent way to obtain a Bachelor of Science in Nursing without disrupting their work-life balance. These programs enhance clinical knowledge and open pathways to leadership positions.

Additionally, healthcare professionals targeting administrative or leadership roles might explore the fastest online master's in healthcare management. This degree focuses on efficient healthcare operations and policy, preparing graduates to manage complex medical organizations effectively.

Best Scientists Contributing to This Journal

Recently Published Articles